With pos­i­tive PhI­II da­ta in hot flash­es, Bay­er is a step clos­er to chal­leng­ing Astel­las’ Veozah

Bay­er’s non-hor­mon­al drug can­di­date for hot flash­es in post­menopausal women has suc­ceed­ed in the last of a trio of reg­is­tra­tional tri­als, set­ting the stage for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER